Adagene (ADAG) Current Leases (2022 - 2025)
Adagene's (ADAG) quarterly Current Leases came in at $92.1 billion in Q4 2025, down 34.87% year-on-year from $141.3 billion in Q4 2024, and up 73145921.88% on a QoQ basis from $125851.0 in Q2 2025.
Adagene (ADAG) Current Leases (2022 - 2025) Analysis & Trends
Adagene (ADAG) has 4 years of Current Leases data on file, last reported at $92.1 billion in Q4 2025.
- On a quarterly basis, Current Leases fell 34.87% year-over-year to $92.1 billion in Q4 2025; TTM through Dec 2025 was $92.1 billion, a 34.87% decrease from a year earlier, with the FY2025 full-year figure at $92.1 billion, down 34.87% from the prior year.
- Current Leases for Q4 2025 stood at $92.1 billion, up from $125851.0 in the prior quarter.
- Over the last five years, Current Leases for ADAG reached as high as $297.1 billion in Q2 2022 and fell as low as $125851.0 in Q2 2025.
- Historically, Current Leases has averaged $129.7 billion across 4 years, with a median of $146.7 billion in 2022.
- Across the five-year window, Current Leases climbed 28.93% in 2023 and slumped 100.0% in 2024, its largest moves.
- Year by year, Current Leases stood at $152.0 billion in 2022, then increased by 28.93% to $196.0 billion in 2023, then retreated by 27.87% to $141.3 billion in 2024, then sank by 34.87% to $92.1 billion in 2025.
- Per Business Quant data, the three most recent Current Leases figures were $92.1 billion in Q4 2025, $125851.0 in Q2 2025, and $141.3 billion in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Adagene | 198.85 Mn | 198.85 Mn | - | 92.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 92.06 Bn |
| Jun 30, 2025 | 125,851.00 |
| Dec 31, 2024 | 141.34 Bn |
| Jun 30, 2024 | 141,281.00 |
| Dec 31, 2023 | 195.96 Bn |
| Jun 30, 2023 | 158.86 Bn |
| Dec 31, 2022 | 151.98 Bn |
| Jun 30, 2022 | 297.07 Bn |